AI-generated summary
This randomised pilot trial of 60 cancer patients with chemotherapy-induced peripheral neuropathy compared two photobiomodulation fluences. The authors report significant improvement over time in neuropathy scores and walking test performance, and pain scores were better in the 6 J/cm² group. No significant changes were found in overall quality of life.
- Participants
- 60
- Who or what was studied
- Cancer patients with chemotherapy-induced peripheral neuropathy treated at Jessa Hospital, Belgium
- Limits stated in the abstract
- The abstract describes a pilot trial whose findings the authors say need future research to support them.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Neuropathy, Fluence, Photobiomodulation therapy, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.